Concord Biotech Ltd
NSE:CONCORDBIO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 230.7
2 345.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
CONCORDBIO Price Targets Summary
Concord Biotech Ltd
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 542.75 INR with a low forecast of 1 302.9 INR and a high forecast of 1 764 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CONCORDBIO's stock price target?
Price Target
1 542.75
INR
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 542.75 INR with a low forecast of 1 302.9 INR and a high forecast of 1 764 INR.
What is Concord Biotech Ltd's Revenue forecast?
Projected CAGR
19%
For the last 4 years the compound annual growth rate for Concord Biotech Ltd's revenue is 18%. The projected CAGR for the next 3 years is 19%.
What is Concord Biotech Ltd's Operating Income forecast?
Projected CAGR
17%
For the last 4 years the compound annual growth rate for Concord Biotech Ltd's operating income is 11%. The projected CAGR for the next 3 years is 17%.
What is Concord Biotech Ltd's Net Income forecast?
Projected CAGR
19%
For the last 4 years the compound annual growth rate for Concord Biotech Ltd's net income is 12%. The projected CAGR for the next 3 years is 19%.
